Uronis named associate clinical director of DCI
The Duke Cancer Institute has announced that Hope E. Uronis, MD, MHS, associate professor of medicine (Medical Onocology), will be DCI's associate clinical director.
In this capacity, Dr.
Funding opp: DCI Cancer Survivorship Center pilot research projects
The Duke Cancer Institute (DCI) is pleased to announce the first round of funding for the Cancer Survivorship Center pilot research projects.
DoM faculty, trainees to present at ASCO's Quality Care Symposium Nov. 1-2
This weekend a number of Department of Medicine faculty and trainees will be participating in the American Society of Clinical Oncology's Quality Care Symposium, which brings together leaders in the field to share new strategies, methods, and technologies for measuring and improving the quality of cancer care.
Here's a list of those who will be representing Duke:
- "Developing a virtual collaborative to facilitate palliative care and quality improvement learning in oncology." Kamal, McNiff, Prestrud, Lupu, Zafar, Gavigan, Schilsky, Abernethy.
Ubel, Abernethy and Zafar on Out-of-pocket costs as side effects in NEJM
Peter Ubel, MD, professor of business administration, medicine and public policy; Amy Abernethy, MD, PhD, associate professor of medicine (Medical Oncology); and Yousuf Zafar, MD, MHS, assistant professor of medicine (Medical Oncology), have an article in this week's New England Journal of Medicine that looks at disclosing the financial consequences of treatments to patients.
Grand Rounds 10/11/13: Colorectal Cancer Treatment and Prevention
[caption id="attachment_13367" align="alignright" width="175"]
Charles S. Fuchs, MD, MPH[/caption]
Medicine Grand Rounds on Fri., Oct. 11 at 8 a.m.
Charles S. Fuchs, MD, MPH[/caption]
Medicine Grand Rounds on Fri., Oct. 11 at 8 a.m.
Abernethy recognized by American Academy of Hospice and Palliative Medicine
Amy Abernethy, MD, associate professor medicine (Medical Oncology) and director of the Duke Cancer Care Research Program and Center for Learning Health Care, was named one of the 30 most influential leaders in hospice and palliative medicine by the Amer
MD Anderson's James Abbruzzese selected chief of Division of Medical Oncology
Mary Klotman, MD, chair of the Department of Medicine, and Michael Kastan, MD, PhD, executive director of the Duke Cancer Institute, announced today that James Abbruzzese, MD, has agreed to be the Chief of the Division of Medical Oncology and Associate Di
Peppercorn named founding director of Duke Cancer Survivorship Center
Jeffrey Peppercorn, MD, MPH, associate professor of medicine (Medical Oncology) has been named founding director of the Duke Cancer Institute's newly relaunched Duke Cancer Survivorship Center.
Meet your chief resident: Krish Patel, MD
[caption id="attachment_12898" align="alignright" width="210"]
Krish Patel, MD[/caption]
Since he became the chief resident of Internal Medicine for Duke University Hospital, Krish Patel, MD, has learned first-hand the many logistical details in the Internal Medicine Residency Program.
“There’s a part of my role that ends up being schedu
Krish Patel, MD[/caption]
Since he became the chief resident of Internal Medicine for Duke University Hospital, Krish Patel, MD, has learned first-hand the many logistical details in the Internal Medicine Residency Program.
“There’s a part of my role that ends up being schedu
Duke investigators receive grants from Susan G. Komen for breast cancer research
Susan G. Komen announced $3.6 million in research funding would go to 10 programs at Duke University and UNC-Chapel Hill.